Stephen Baxter

Q: What is Stephen Baxter's success rate?

Stephen Baxter currently has a success rate of 92.7981151259328.

Q: What is the average return of Stephen Baxter's calls?

Their stock ratings have generated an average return of 11.680095623452756.

Wells Fargo | Healthcare

Stephen Baxter is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #1741 out of 4773 analysts, they have issued 88 stock ratings with a success rate of 92.80% and an average return of 11.68%.

Stephen Baxter has a well-established track record, with 88 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.80% and an average return of 11.68%, underscoring their expertise and ability to identify winning opportunities for investors.

#1741

Out of 4773

Total Ratings

+92.80%

Success Rate

+11.68%

Average Return

Recent Ratings Analysis

THC

Buy

Aug 03, 2026

Target

$281.00

Current

$263.69

Performance

5.48%

Stephen Baxter rated THC as Overweight on Aug 03, 2026, setting a price target of 281. The call has proven timely, with shares rising 5.48% toward the price target of 281.

HCA

Hold

Aug 03, 2026

Target

$381.00

Current

$426.94

Performance

5.00%

On Aug 03, 2026, HCA was given a Equal-Weight rating by Stephen Baxter, with a target price of 381. Market indecision, reflected in sideways trading near 426.94, supported the cautious call.

CI

Hold

Jul 31, 2026

Target

$307.00

Current

$280.76

Performance

0.61%

CI received a Equal-Weight rating from Stephen Baxter on Jul 31, 2026, aiming for 307. Shares remained flat at 280.76, aligning with the neutral rating.

MOH

Hold

Jul 28, 2026

Target

$220.00

Current

$204.23

Performance

1.94%

On Jul 28, 2026, Stephen Baxter published a Equal-Weight outlook on MOH, with a target of 220. Sideways action left the Hold view intact, with no major move since 204.23.

ELV

Buy

Jul 16, 2026

Target

$473.00

Current

$418.72

Performance

12.30%

Stephen Baxter on Jul 16, 2026 assigned ELV a Overweight rating, with a price target of 473. The Buy call aligned well with market performance, producing a gain of 12.30%.

CNC

Hold

Jul 13, 2026

Target

$69.00

Current

$66.40

Performance

-2.77%

On Jul 13, 2026, Stephen Baxter reaffirmed CNC with a Equal-Weight rating, targeting 69. The neutral call matched muted market action of -2.77%.

AGL

Buy

Jul 13, 2026

Target

$141.00

Current

$89.77

Performance

-22.51%

AGL was rated Overweight by Stephen Baxter on Jul 13, 2026, with a price objective of 141. This case shows how bullish projections can fail, with the stock now below 89.77.

BTSG

Buy

Jul 13, 2026

Target

$78.00

Current

$58.73

Performance

-15.67%

On Jul 13, 2026, Stephen Baxter initiated coverage on BTSG with a Overweight rating and target of 78. The Buy call has yet to be validated as shares remain 19.27 away from the target.

CVS

Buy

Jul 13, 2026

Target

$123.00

Current

$94.66

Performance

-10.61%

Stephen Baxter issued a Overweight recommendation for CVS on Jul 13, 2026, price target set at 123. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

PNTG

Buy

Jul 13, 2026

Target

$45.00

Current

$39.20

Performance

-1.66%

On Jul 13, 2026, PNTG was evaluated by Stephen Baxter, who gave a Overweight rating and target of 45. So far, the Buy call awaits clearer momentum, with shares flat at 39.2.

UHS

Hold

Jul 13, 2026

Target

$166.00

Current

$174.83

Performance

14.44%

Stephen Baxter rated UHS as Equal-Weight on Jul 13, 2026, setting a price target of 166. Despite the Hold call, shares climbed 14.44% to 174.83, revealing unexpected momentum.

UNH

Buy

Jul 13, 2026

Target

$485.00

Current

$379.09

Performance

-11.65%

On Jul 13, 2026, UNH was given a Overweight rating by Stephen Baxter, with a target price of 485. Despite the Buy call, shares fell from 379.09 to 379.09, challenging the optimistic stance.

HUM

Buy

Jul 13, 2026

Target

$502.00

Current

$409.85

Performance

0.95%

HUM received a Overweight rating from Stephen Baxter on Jul 13, 2026, aiming for 502. Price action was muted, as shares hovered around 409.85 despite the bullish outlook.

MCK

Hold

May 12, 2026

Target

$812.00

Current

$881.51

Performance

19.98%

On May 12, 2026, Stephen Baxter published a Equal-Weight outlook on MCK, with a target of 812. The Hold call missed some of the bullish momentum as shares advanced toward 812.

COR

Buy

May 11, 2026

Target

$331.00

Current

$321.57

Performance

23.82%

Stephen Baxter on May 11, 2026 assigned COR a Overweight rating, with a price target of 331. The Buy call aligned well with market performance, producing a gain of 23.82%.

CAH

Buy

May 01, 2026

Target

$245.00

Current

$234.57

Performance

—

On May 01, 2026, Stephen Baxter reaffirmed CAH with a Overweight rating, targeting 245. Market indecision has kept the 245 target in a holding pattern.

CON

Buy

Mar 05, 2026

Target

$28.00

Current

$34.95

Performance

—

CON was rated Overweight by Stephen Baxter on Mar 05, 2026, with a price objective of 28. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

MDLN

Hold

Feb 27, 2026

Target

$47.00

Current

$32.53

Performance

-31.53%

On Feb 27, 2026, Stephen Baxter initiated coverage on MDLN with a Equal-Weight rating and target of 47. The rating matched the stock’s inability to hold above 32.53.

CYH

Sell

Jan 07, 2026

Target

$3.00

Current

$2.92

Performance

-10.43%

Stephen Baxter issued a Underweight recommendation for CYH on Jan 07, 2026, price target set at 3. The Sell call exposed risks of betting against momentum, as the stock rallied -10.43%.

OSCR

Sell

Nov 13, 2025

Target

$11.00

Current

$32.77

Performance

134.91%

On Nov 13, 2025, OSCR was evaluated by Stephen Baxter, who gave a Underweight rating and target of 11. Investors benefited from heeding the Sell stance, avoiding a 134.91% decline.

TDOC

Hold

Apr 29, 2024

Target

$15.00

Current

$6.16

Performance

-54.00%

Stephen Baxter rated TDOC as Equal-Weight on Apr 29, 2024, setting a price target of 15. The cautious Hold call aligned with subsequent weakness, as shares slipped 54.00%.

Frequency Asked Questions

Who is Stephen Baxter?

Stephen Baxter is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Stephen Baxter's success rate?

Stephen Baxter currently has a success rate of +92.80%.

How many ratings has Stephen Baxter issued?

Stephen Baxter has issued 88 stock ratings so far.

What is the average return of Stephen Baxter's calls?

Their stock ratings have generated an average return of +11.68%.

What is Stephen Baxter's ranking?

Stephen Baxter is ranked #1741 out of 4773 analysts.

What types of ratings does Stephen Baxter give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Stephen Baxter?

You can follow Stephen Baxter by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Stephen Baxter?

Their latest rating was a Buy on THC issued on 2026-08-03.